Latest Health News
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement
DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB),…
Ocular Therapeutix to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026
February 13, 2026 17:00 ET | Source: Ocular Therapeutix, Inc. Ocular to…
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
February 12, 2026 21:18 ET | Source: Coherus Oncology, Inc. REDWOOD CITY,…
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million…
Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance generation of real-world evidence in MG
Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided…
